Thymoquinone reduces spinal cord injury by inhibiting inflammatory response, oxidative stress and apoptosis via PPAR-γ and PI3K/Akt pathways
- 1 June 2018
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 15 (6), 4987-4994
- https://doi.org/10.3892/etm.2018.6072
Abstract
The present study used a mild contusion injury in rat spinal cord to determine that thymoquinone reduces inflammatory response, oxidative stress and apoptosis in a spinal cord injury (SCI) rat model and to demonstrate its possible molecular mechanisms. The rats in the thymoquinone group received 30 mg/kg thymoquinone once daily by intragastric administration from 3 weeks after surgery. Hematoxylin and eosin staining, Basso, Beattie and Bresnahan (BBB) scale and tissue water content detection were used in the present study to analyze the effect of thymoquinone on SCI. The activity of inflammatory response mediators, oxidative stress factors and caspase-3/9 was measured using ELISA kits. Furthermore, western blotting was performed to analyzed the protein expression levels of prostaglandin E2, suppressed cyclooxygenase-2 (COX-2) and activated peroxisome proliferator-activated receptor gamma (PPAR-gamma), PI3K and Akt. The results from the study demonstrated that thymoquinone increased Basso, Beattie and Bresnahan score and decreased water content in spinal cord tissue. Treatment with thymoquinone decreased inflammatory response [measured by levels of tumor necrosis factor alpha, interleukin (IL)-1 beta, IL-6 and IL-18], oxidative stress (measured by levels of superoxide dismutase, catalase, glutathione and malondialdehyde) and cell apoptosis (measured by levels of caspase-3 and caspase-9) in SCI rats. Thymoquinone treatment inhibited prostaglandin E2 activity, suppressed COX-2 protein expression and activated PPAR-gamma, PI3K and p-Akt protein expression in SCI rats. These data revealed that thymoquinone reduces inflammatory response, oxidative stress and apoptosis via PPAR-gamma and PI3K/Akt pathways in an SCI rat model.This publication has 39 references indexed in Scilit:
- Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord traumaJournal of Neuroinflammation, 2013
- Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injurySpinal Cord, 2013
- Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical applicationActa Neuropathologica, 2011
- Apoptosis of neurons and oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy): possible pathomechanism of human cervical compressive myelopathyEuropean Spine Journal, 2011
- Forced, moderate-intensity treadmill exercise suppresses apoptosis by increasing the level of NGF and stimulating phosphatidylinositol 3-kinase signaling in the hippocampus of induced aging ratsNeurochemistry International, 2009
- PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanismsBrain Research, 2008
- Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cordNeuroscience, 2008
- Potential Therapeutic Targets for PPAR after Spinal Cord InjuryPPAR Research, 2008
- Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injuryPurinergic Signalling, 2007
- Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neuronsNeurochemistry International, 2007